Crowdstake

ALCMI

EIN: 26-1721868 · San Carlos, CA

Lung Cancer Research
Genomic Markers in Young Lung Cancer Patients
Understanding Hereditary Risk Factors
Resistance Mechanisms in Lung Cancer

Our Story

The Addario Lung Cancer Medical Institute (ALCMI) was founded in 2008 with a mission to make lung cancer a survivable disease. By partnering with leading oncology research institutions, ALCMI provides essential funding, staff, and expertise for investigator-initiated clinical trials.

Impact

ALCMI has completed 23 clinical trials and published findings in prestigious oncology journals, significantly enhancing the understanding of lung cancer and its treatment.

Why Donate?

Your donation to ALCMI supports critical lung cancer research, accelerating the development of new therapies and diagnostics that improve patient outcomes and survival rates.

Get Involved

Join the fight against lung cancer by donating today. Your contribution, whether in cryptocurrency or cash, can help transform lives and advance groundbreaking research.

Do you represent ALCMI? Sign up and claim this page to customize it and gain access to our dashboard. Learn More.